SCHEMBL23502218

SCHEMBL23502218

c1ccc2cc(-c3c4ccccc4c(-c4ccc5c(c4)c4ccccc4c4ccc6oc7ccccc7c6c45)c4ccccc34)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ CYP1A1 P04798 2/20 0.38
▸ CYP1B1 Q16678 1/20 0.38
▸ CASP3 P42574 1/20 0.38
▸ SENP7 Q9BQF6 1/20 0.38
▸ SENP6 Q9GZR1 1/20 0.38
▸ NPC1 O15118 3/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ CYP1A2 P05177 3/20 0.35
▸ HCRTR1 O43613 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ ABCG2 Q9UNQ0 5/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ HPGD P15428 3/20 0.34
▸ AHR P35869 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ MAPT P10636 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23502253 1.00 TDP1 (0.40) TDP1L3MBTL1CYP1A1CYP1B1CASP3
SCHEMBL23502087 0.94 CYP1A1 (0.40) TDP1L3MBTL1CYP1A1CYP1B1CASP3
SCHEMBL22155123 0.92 PLA2G2A (0.39) TDP1L3MBTL1CYP1A1CYP1B1CASP3
SCHEMBL23502214 0.92 CYP1A1 (0.40) TDP1L3MBTL1CYP1A1CYP1B1NPC1
SCHEMBL17944470 0.91 CASP3 (0.41) TDP1L3MBTL1CYP1A1CYP1B1CASP3
SCHEMBL17945562 0.90 TDP1 (0.43) TDP1L3MBTL1CYP1A1CYP1B1CASP3
SCHEMBL23502290 0.89 ALOX5 (0.42) TDP1L3MBTL1CASP3SENP7SENP6
SCHEMBL17944007 0.88 CYP1A1 (0.40) TDP1L3MBTL1CYP1A1CYP1B1CASP3
SCHEMBL19108559 0.87 HCRTR1 (0.41) TDP1L3MBTL1CYP1A1CYP1B1CASP3
SCHEMBL17932120 0.87 CASP3 (0.41) TDP1L3MBTL1CYP1A1CYP1B1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11038124-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2021-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11038124-B2 Organic compound and organic electroluminescence device using the same TRPA1, TRPC6, TRPM4 TDP1 3796/4885L3MBTL1 271/4885CYP1A1 926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback